drug · small molecule
patient view →PAX-101
Phase 3updated 2mo agoby Kuvatris Therapeutics Inc🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for leishmaniasis and trypanosomiasis and 11 investigational indications.
targets
Fibroblast growth factor 1
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that